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Genetically obese (ob/ob) mice develop a marked insulin resistance in brown adipose tissue soon after wean- 
ing, and this is paralleled by a fall in the acute activation of the mit~hond~al proton conductance pathway 
in the tissue on cold exposure. Treatment of ob/ob mice with ciglitazone, a new oral hypoglycaemic, led 
to a restoration of insulin sensitivity in brown adipose tissue. The amelioration of insulin resistance was 
accompanied by a normalization of the acute, cold-induced increase in mitochondrial GDP binding. These 
results support the hypothesis that the development of insulin resistance in brown adipose tissue is an impor- 
tant factor in the impaired thermogenic responsiveness of obese mice. 
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1. INTRODUCTION 
The genetically obese (oblob) mouse has a 
reduced energy expenditure on brown adipose 
tissue (BAT) thermogenesis when maintained 
under normal environmental conditions, and this 
is now regarded as being central to the develop- 
ment of the obese state (review [l])_ The primary 
mechanism for thermogenesis n BAT is a proton 
conductance pathway across the inner mitochon- 
drial membrane [2]. The activity of this pathway, 
which is generally assessed in vitro from the 
binding of GDP to isolated mitochondria, is 
substantially reduced in ob/ob mice maintained at 
normal temperatures 13-51. In addition to this ab- 
normality, and in contrast to lean animals, adult 
ob/ob mice fail to exhibit an activation of the pro- 
ton conductance pathway in response to acute cold 
exposure [3]. 
Recent studies have indicated that in ob/ob mice 
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with the ob gene on the ‘Aston’ background, the 
defective acute cold-induced activation of ther- 
mogenesis in BAT develops during the fifth week 
of life [5]; in 26-day-old animals a normal response 
to cold occurs, but by 35 days of age the defect is 
evident. The defective acute activation of ther- 
mogenesis is not due to a limitation in the amount 
of uncoupling protein 151. It does, however, coin- 
cide with the appearance of insulin resistance in 
BAT of the ob/ob mouse [5,6], which has led us to 
propose that insulin resistance in the tissue may be 
the cause of the impairment in thermogenic 
responsiveness, through limiting glucose uptake 
I51. 
In the present study we have investigated the ef- 
fects of treatment with an oral hypogiycaemic, 
ciglitazone [7-l 11, on the restoration of insulin 
sensitivity in BAT of ob/ob mice, together with the 
consequences for thermogenic responsiveness. The 
results show that ciglitazone is effective in 
ameliorating insulin resistance in BAT, as 
demonstrated by the stimulation of lipogenesis by 
insulin, and this is paralleled by a normalization of 
the activation of the proton conductance pathway 
on acute exposure to cold. 
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2. MATERIALS AND METHODS 
2.1. Animals 
Male lean (ob/ + or + / + ) and obese (ob/ob) 
mice of the Aston variety were taken at 30-40 days 
of age, and fed for 7 days on either a powdered 
stock diet (LAD-l, K and K Greef Chemicals, 
Croydon, England) alone, or powdered stock diet 
containing ciglitazone (1 g/kg diet). Ciglitazone, 
5-[4-(1 -methylcyclohexylmethoxy)benzyl]thiazoli- 
dine-2,4-dione, was a gift from Dr A.Y. Chang 
(Upjohn Co., Kalamazoo, USA). Both food and 
tap water were available ad libitum. Lean and 
obese littermates were housed in pairs in plastic 
cages containing sawdust bedding, and maintained 
in a room at 22 + 1°C with a 12 h light/l2 h dark 
cycle (lights from 07.00 h). 
isophane insulin injection BP, Wellcome Founda- 
tion Ltd, London, England) 40 rnin before the in- 
jection of 3Hz0 [5]. Control animals received a 
saline injection. Tissues were removed 60 min after 
the administration of ‘Hz0 and processed as in 
]6,121. 
2.3. Mitochondrial GDP-binding assay 
The activity of the mitochondrial proton con- 
ductance pathway was assessed by GDP-binding 
studies [3,13]. BAT was removed from the in- 
terscapular and subscapular sites, which were then 
pooled and mitochondria isolated [ 131. The 
mitochondria were incubated for 7 min at room 
temperature with 10pM [3H]GDP as described 
15,131. 
In studies involving the effects of acute cold ex- 
posure, the mice were transferred to a room at 4 + 
1°C for 1 h and caged individually in wire mesh 
cages without bedding material. 
Radiochemicals were obtained from Amersham 
Internatiopnal (Amersham, England). The statis- 
tical significance of differences between groups 
was assessed by Student’s t-test. 
2.2. Lipogenesis 
3. RESULTS 
Rates of lipogenesis were measured in vivo, with Table 1 shows that the administration of insulin 
3Hz0 as described [6,12]. The measurements were to normal lean mice led to a substantial increase in 
made between 08.30 and 11 .OO h. To examine the the rate of lipogenesis in interscapular BAT. 
effect of insulin on lipogenesis, lean and obese Although the ‘basal’ rate of lipogenesis in the in- 
mice were injected subcutaneously with 10 units terscapular pad was higher in the control obese 
isophane insulin/kg body wt (‘Neuphane’ animals than in the lean, the increase was not 
Table 1 
Effect of insulin on the rates of lipogenesis in brown adipose tissue of untreated or 
ciglitazone-treated lean and obese (ob/ob) mice 
Lipogenesis bgatom H incorporated/h per tissue) 
Lean Obese 




12.8 + 3.7 56.1 + 3.7a 18.3 f 2.2 17.5 f 1.2 
(6) (6) (6) (6) 
12.1 f 1.7 43.5 + 2.7a 24.0 + 1.4 44.0 f 3.1= 
(5) (5) (6) (6) 
a p < 0.001 compared with control animals of the same genotype and in the same 
treatment group 
Lean and obese mice were given ciglitazone in the diet (1 g/kg) for 7 days. Insulin or 
saline (controls) was injected subcutaneously 40 min before the administration of 
‘H20. Interscapular brown adipose tissue was removed 60 min after the injection of 
3H20. For full experimental details see text. The results are given as mean values f 
SE for the number of animals shown in parentheses 
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statistically significant. In contrast to the lean 
mice, the administration of high doses of insulin to 
the obese animals had no effect on the rate of 
lipogenesis in BAT, which is in agreement with 
previous work on ob/ob mice of a similar age [5]. 
The addition of ciglitazone in the diet for 7 days 
had no effect on the weight gain of either lean or 
obese mice, nor was there any effect on the weight 
of the interscapular BAT pad. Glycosuria was evi- 
dent in 92% (23 out of 25) of the untreated obese 
mice, but after treatment with ciglitazone only 
11.5% (3 out of 26) of the obese animals were 
glycosuric (not shown). 
Treatment of lean mice with ciglitazone had no 
effect on the basal rate of lipogenesis in BAT, and 
insulin produced a marked stimulation of 
lipogenesis in the treated lean animals. The basal 
rates of lipogenesis in obese mice treated with 
ciglitazone were higher than in the lean animals 
(treated or untreated), and the administration of 
insulin to the treated obese mice resulted in a 
significant stimulation of lipogenesis. The 
lipogenic rate in the ciglitazone-treated obese 
animals after the injection of insulin was similar to 
that in the treated lean group. Thus ciglitazone 
leads to the amelioration of the insulin resistance 
of BAT in ob/ob mice, with respect to the 
stimulatory effects of insulin on lipogenesis. 
In the second set of experiments the activity of 
the mitochondrial proton conductance pathway 
was assessed by GDP-binding studies in untreated 
and ciglitazone-treated mice maintained at room 
temperature or exposed acutely to cold. As in the 
first experiments lean and obese animals were 
treated with ciglitazone for 7 days. The results in 
table 2 show that for mice maintained at 22°C 
GDP binding was lower in the obese than in the 
lean, and that treatment with ciglitazone had no 
significant effect on the level of binding in either 
genotype. 
Acute exposure to cold for 1 h led to a marked 
increase in the level of GDP binding in the un- 
treated lean mice, but in the untreated obese 
animals there was virtually no change. However, 
after treatment with ciglitazone the obese animals 
showed a substantial rise in GDP binding on cold 
exposure, and the rise was similar to that of the 
lean (treated and untreated). Thus ciglitazone nor- 
malized the acute thermogenic response to cold in 
ob/ob mice. 
Table 2 
Effect of acute cold exposure on GDP binding to brown adipose tissue 
mitochondria of untreated or ciglitazone-treated lean and obese (ob/ob) 
mice 
Treatment Mice GDP bound 
(pmol/mg mitochondrial protein) 
22°C 4°C Increase 
at 4°C 
Untreated lean 215.0 f 15.5 327.1 k 47.5= 112.1 
(7) (6) 
Untreated obese 125.5 k 25.1 137.3 * 11.7 11.8 
(7) (6) 
Ciglitazone lean 231.5 Y!I 30.5 355.0 f 70.0b 123.5 
(7) (7) 
Ciglitazone obese 187.1 t- 30.1 301.3 f 32.1”’ 114.2 
(7) (7) 
a p < 0.05 compared with mice of the same group at 22°C 
b p < 0.02, ‘p < 0.01 compared with the untreated obese mice at 4°C 
Mice were treated with ciglitazone as in the legend to table 1. GDP 
binding was measured in mice maintained at 22”C, and in mice exposed 
to a temperature of 4°C for 1 h. The results are given as mean values f 
SE with the number of animals shown in parentheses 
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4. DISCUSSION 
BAT is now established as being an important 
site of lipogenesis in rats and mice, particularly 
following cold adaptation [ 12,14,15]. Recent 
studies have indicated that there is a marked 
hyperlipogenesis in BAT of ob/ob mice in the 
period immediately after weaning, and this has 
been attributed to the substantial hyperin- 
sulinaemia occurring in the mutant [6] since 
lipogenesis in the tissue is stimulated by insulin 
114,151. During the fifth week of life there is a 
sharp fall in the rate of lipogenesis in BAT of 
ob/ob mice, despite continuing hyperinsulinaemia, 
indicating that the tissue becomes insulin resistant 
[61. 
The development of insulin resistance in BAT of 
the ob/ob mutant occurs at the same time as an im- 
pairment in the thermogenic response to acute cold 
exposure, and we have suggested that there may be 
a causal link between the two abnormalities [5]. 
This proposition was examined here by in- 
vestigating the effects of restoring insulin sensitivi- 
ty in BAT on thermogenic responsiveness, using a 
new oral hypoglycaemic, ciglitazone. 
Ciglitazone was selected for use in these ex- 
periments since it has recently been found to be 
highly effective in ameliorating insulin resistance 
in ob/ob mice, and other types of obese animal 
[7-111. Its effects on BAT have not, however, 
been previously reported. Chronic treatment of 
ob/ob mice with ciglitazone appears to reverse suc- 
cessfully insulin resistance in BAT, as indicated by 
the restoration of the stimulatory effects of insulin 
on lipogenesis in the tissue. 
The mechanism of action of ciglitazone is not 
well understood. The compound, when ad- 
ministered in vivo, has been found to increase the 
number of cell-surface insulin receptors in white 
adipose tissue of the ob/ob mouse [B]. However, 
this effect may be secondary to the reduction in the 
severity of hyperinsulinaemia that occurs in 
ciglitazone-treated ob/ob mice [7,9], since in vitro 
studies have suggested that the direct action of 
ciglitazone occurs at a step, or steps, distal to the 
insulin receptor [ 11,161. 
The amelioration of insulin resistance in BAT by 
ciglitazone was accompanied by a normalization of 
the acute activation of the proton conductance 
pathway on cold exposure. This is clearly consis- 
tent with the suggestion that the development of an 
impaired response to acute cold in ob/ob mice is 
caused initially by insulin resistance in BAT [5]. 
The appearance of a thermogenic abnormality dur- 
ing the fifth week of life in ob/ob mice is not due 
to any limitation in the amount of uncoupling pro- 
tein, since the concentration of the protein is nor- 
mal at this stage [5,17], although there is a decline 
subsequently [17]. It also cannot be ascribed to a 
defective activation of sympathetic outflow to 
BAT, since noradrenaline turnover in the tissue of 
obese mutants is increased normally on acute cold 
exposure [18,19]. 
Insulin may play a role in the central stimulation 
of thermogenesis n BAT via activation of the sym- 
pathetic nervous system [20,21], but it also has 
direct effects on the tissue. In addition to ac- 
tivating pyruvate dehydrogenase and acetyl-CoA 
carboxylase [14,151, insulin stimulates glucose up- 
take by BAT [22], and the tissue may be quan- 
titatively important in the removal of glucose from 
blood [22-261. Studies with 2-deoxyglucose in- 
dicate that glucose uptake by BAT is stimulated by 
noradrenaline [22] and acute cold exposure [5]. In- 
sulin resistance in BAT of ob/ob mice leads to a 
loss of the cold-induced increase in glucose uptake 
[5], and this is likely to be the explanation for the 
development of the impaired thermogenic response 
to cold. Whether glucose is required by BAT as a 
direct substrate during acute cold exposure [ 151, or 
as a source of oxaloacetate to support a rapid in- 
crease in fatty acid oxidation [27], is not clear. 
In conclusion, although this study and our 
previous work [5] have focussed on the ther- 
mogenic responses to cold, it is possible that the 
development of insulin resistance in BAT could 
also be important in the impairment in diet- 
induced thermogenesis in obese animals. 
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